Funds and ETFs Hangzhou Tigermed Consulting Co., Ltd
Equities
300347
CNE100001KV8
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
55.5 CNY | +3.54% | +0.31% | +0.96% |
Apr. 25 | Hangzhou Tigermed Consulting’s Profit Down 59% in Q1 | MT |
Apr. 25 | Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024 | CI |
ETFs positioned on Hangzhou Tigermed Consulting Co., Ltd
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.98% | 1 M€ | -9.86% | - | |
0.69% | 2 M€ | -17.32% | - | |
0.18% | 35 M€ | -5.85% | - | |
0.02% | 2 M€ | -.--% | ||
0.02% | 7 M€ | -.--% | - | |
0.02% | 4 M€ | -11.56% | ||
0.01% | 112 M€ | +3.89% | - | |
0.00% | 2,867 M€ | +5.51% | - | |
0.00% | 153 M€ | +5.46% | - | |
0.00% | 454 M€ | +5.22% | - | |
0.00% | 32 M€ | +6.31% | - | |
0.00% | 4 M€ | -4.41% | - | |
0.00% | 34 M€ | +8.31% | - | |
0.00% | 34 M€ | +3.48% | - | |
0.00% | 39 M€ | +6.05% | - | |
0.00% | 306 M€ | +5.68% | - | |
0.00% | 17 M€ | +2.99% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.96% | 5.98B | |
+45.48% | 56.65B | |
-6.42% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.14% | 26.75B | |
-21.38% | 19.03B | |
+0.40% | 12.28B | |
+23.85% | 12.26B | |
+27.70% | 12.04B |
- Stock Market
- Equities
- 300347 Stock
- Funds and ETFs Hangzhou Tigermed Consulting Co., Ltd